Morgan Stanley’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14
| Closed | -$6 | – | 8342 |
|
|
2024
Q4 | $6 | Hold |
14
| – | – | ﹤0.01% | 7928 |
|
|
2024
Q3 | $28 | Hold |
14
| – | – | ﹤0.01% | 7757 |
|
|
2024
Q2 | $75 | Hold |
14
| – | – | ﹤0.01% | 7405 |
|
|
2024
Q1 | $42 | Sell |
14
-226
| -94% | -$1.06K | ﹤0.01% | 7547 |
|
|
2023
Q4 | $1.51K | Sell |
240
-133
| -36% | -$1.02K | ﹤0.01% | 7167 |
|
|
2023
Q3 | $8.23K | Buy |
373
+67
| +22% | +$1.75K | ﹤0.01% | 6795 |
|
|
2023
Q2 | $2.16K | Buy |
306
+157
| +105% | +$3.61K | ﹤0.01% | 7179 |
|
|
2023
Q1 | $6.85K | Sell |
149
-12
| -7% | -$1.31K | ﹤0.01% | 6987 |
|
|
2022
Q4 | $22.8K | Buy |
161
+76
| +89% | +$15.6K | ﹤0.01% | 6634 |
|
|
2022
Q3 | $48K | Buy |
85
+61
| +254% | +$40.1K | ﹤0.01% | 6432 |
|
|
2022
Q2 | $19K | Sell |
24
-14
| -37% | -$20.7K | ﹤0.01% | 7014 |
|
|
2022
Q1 | $101K | Buy |
38
+13
| +52% | +$27.6K | ﹤0.01% | 6303 |
|
|
2021
Q4 | $64K | Sell |
25
-9
| -26% | -$31.3K | ﹤0.01% | 6690 |
|
|
2021
Q3 | $154K | Sell |
34
-2
| -6% | -$10.1K | ﹤0.01% | 6130 |
|
|
2021
Q2 | $212K | Buy |
36
+2
| +6% | +$12.9K | ﹤0.01% | 5987 |
|
|
2021
Q1 | $278K | Buy |
34
+20
| +143% | +$212K | ﹤0.01% | 5470 |
|
|
2020
Q4 | $86K | Buy |
14
+11
| +367% | +$67.3K | ﹤0.01% | 5973 |
|
|
2020
Q3 | $18K | Buy |
3
+1
| +50% | +$7.41K | ﹤0.01% | 6104 |
|
|
2020
Q2 | $15K | Hold |
2
| – | – | ﹤0.01% | 6069 |
|
|
2020
Q1 | $8K | Sell |
2
-252
| -99% | -$1.05M | ﹤0.01% | 6088 |
|
|
2019
Q4 | $1.49M | Buy |
254
+25
| +11% | +$236K | ﹤0.01% | 4257 |
|
|
2019
Q3 | $2.86M | Sell |
229
-78
| -25% | -$626K | ﹤0.01% | 3467 |
|
|
2019
Q2 | $2.58M | Sell |
307
-28
| -8% | -$328K | ﹤0.01% | 3572 |
|
|
2019
Q1 | $4.4M | Sell |
335
-26
| -7% | -$442K | ﹤0.01% | 2832 |
|
|
2018
Q4 | $5.43M | Buy |
361
+76
| +27% | +$1.79M | ﹤0.01% | 2811 |
|
|
2018
Q3 | $10.6M | Buy |
285
+2
| +0.7% | +$65.9K | ﹤0.01% | 2354 |
|
|
2018
Q2 | $11M | Sell |
283
-30
| -10% | -$1.14M | ﹤0.01% | 2282 |
|
|
2018
Q1 | $10.2M | Buy |
313
+90
| +40% | +$2.42M | ﹤0.01% | 2324 |
|
|
2017
Q4 | $4.6M | Buy |
223
+13
| +6% | +$268K | ﹤0.01% | 3197 |
|
|
2017
Q3 | $4.4M | Buy |
210
+200
| +2,000% | +$3.71M | ﹤0.01% | 3096 |
|
|
2017
Q2 | $153K | Hold |
10
| – | – | ﹤0.01% | 5462 |
|
|
2017
Q1 | $253K | Sell |
10
-6
| -38% | -$169K | ﹤0.01% | 5200 |
|
|
2016
Q4 | $408K | Buy |
16
+11
| +220% | +$339K | ﹤0.01% | 5045 |
|
|
2016
Q3 | $193K | Sell |
5
-1
| -17% | -$32.8K | ﹤0.01% | 5038 |
|
|
2016
Q2 | $250K | Hold |
6
| – | – | ﹤0.01% | 4823 |
|
|
2016
Q1 | $305K | Sell |
6
-4
| -40% | -$177K | ﹤0.01% | 4725 |
|
|
2015
Q4 | $555K | Buy |
10
+1
| +11% | +$53.9K | ﹤0.01% | 4478 |
|
|
2015
Q3 | $412K | Hold |
9
| – | – | ﹤0.01% | 4720 |
|
|
2015
Q2 | $760K | Buy |
9
+1
| +13% | +$86.8K | ﹤0.01% | 4404 |
|
|
2015
Q1 | $594K | Buy |
8
+3
| +60% | +$279K | ﹤0.01% | 4540 |
|
|
2014
Q4 | $472K | Hold |
5
| – | – | ﹤0.01% | 4700 |
|
|
2014
Q3 | $456K | Buy |
+5
| New | +$465K | ﹤0.01% | 4635 |
|
Morgan Stanley's TTOO Position: Q1 2025 in Review
Morgan Stanley sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 14 shares — an estimated $6 sold.
Morgan Stanley first reported a position in TTOO in Q3 2014 and held it in 42 quarters. The position peaked at $11M in Q2 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Morgan Stanley reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Morgan Stanley sold 14 T2 Biosystems, Inc shares in Q1 2025, an estimated $6.
- Morgan Stanley first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 42 quarters.
- Morgan Stanley's T2 Biosystems, Inc position peaked at $11M in Q2 2018.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.